Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa - 07/09/11
Abstract |
Background: Oral isotretinoin has been used to treat mild to severe hidradenitis suppurativa (HS). Objective: We reviewed the results of low-dose isotretinoin for 4 to 6 months in the treatment of 68 patients with HS. Methods: This is a retrospective study. Data are presented in terms of response rate, long-term follow-up, and the relation between response rate and severity. Results: In 16 patients (23.5%), the condition completely cleared during initial therapy and 11 patients (16.2%) maintained their improvement during the follow-up period. Treatment was more successful in the milder forms of HS. Conclusion: Monotherapy with isotretinoin for patients with HS usually has a limited therapeutic effect.(J Am Acad Dermatol 1999;40:73-6.)
Le texte complet de cet article est disponible en PDF.Plan
Reprint requests: J. Boer, MD, PhD, Department of Dermatology, Deventer Hospital, Postbox 5001, 7400 GC Deventer, The Netherlands. |
|
0190-9622/99/$8.00 + 0 16/1/93164 |
Vol 40 - N° 1
P. 73-76 - janvier 1999 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?